ZnO particulate matter requires cell contact for toxicity in human colon cancer cells PJ Moos, K Chung, D Woessner, M Honeggar, NS Cutler, JM Veranth Chemical research in toxicology 23 (4), 733-739, 2010 | 257 | 2010 |
Electrophilic prostaglandins and lipid aldehydes repress redox-sensitive transcription factors p53 and hypoxia-inducible factor by impairing the selenoprotein thioredoxin reductase PJ Moos, K Edes, P Cassidy, E Massuda, FA Fitzpatrick Journal of Biological Chemistry 278 (2), 745-750, 2003 | 195 | 2003 |
Taxane-mediated gene induction is independent of microtubule stabilization: induction of transcription regulators and enzymes that modulate inflammation and apoptosis PJ Moos, FA Fitzpatrick Proceedings of the National Academy of Sciences 95 (7), 3896-3901, 1998 | 161 | 1998 |
Curcumin impairs tumor suppressor p53 function in colon cancer cells PJ Moos, K Edes, JE Mullally, FA Fitzpatrick Carcinogenesis 25 (9), 1611-1617, 2004 | 152 | 2004 |
Combating subclonal evolution of resistant cancer phenotypes SW Brady, JA McQuerry, Y Qiao, SR Piccolo, G Shrestha, DF Jenkins, ... Nature communications 8 (1), 1231, 2017 | 147 | 2017 |
Cyclopentenone prostaglandins of the J series inhibit the ubiquitin isopeptidase activity of the proteasome pathway JE Mullally, PJ Moos, K Edes, FA Fitzpatrick Journal of Biological Chemistry 276 (32), 30366-30373, 2001 | 147 | 2001 |
Thioredoxin reductase is required for the inactivation of tumor suppressor p53 and for apoptosis induced by endogenous electrophiles PB Cassidy, K Edes, CC Nelson, K Parsawar, FA Fitzpatrick, PJ Moos Carcinogenesis 27 (12), 2538-2549, 2006 | 122 | 2006 |
Identification of gene expression profiles that segregate patients with childhood leukemia PJ Moos, EA Raetz, MA Carlson, A Szabo, FE Smith, C Willman, Q Wei, ... Clinical Cancer Research 8 (10), 3118-3130, 2002 | 117 | 2002 |
Transient receptor potential vanilloid 1 agonists cause endoplasmic reticulum stress and cell death in human lung cells KC Thomas, AS Sabnis, ME Johansen, DL Lanza, PJ Moos, GS Yost, ... Journal of Pharmacology and Experimental Therapeutics 321 (3), 830-838, 2007 | 109 | 2007 |
Responses of human cells to ZnO nanoparticles: a gene transcription study PJ Moos, K Olszewski, M Honeggar, P Cassidy, S Leachman, ... Metallomics 3 (11), 1199-1211, 2011 | 106 | 2011 |
Taxanes propagate apoptosis via two cell populations with distinctive cytological and molecular traits PJ Moos, FA Fitzpatrick Cell Growth and Differentiation-Publication American Association for Cancer …, 1998 | 96 | 1998 |
Inactivation of wild-type p53 tumor suppressor by electrophilic prostaglandins PJ Moos, K Edes, FA Fitzpatrick Proceedings of the National Academy of Sciences 97 (16), 9215-9220, 2000 | 88 | 2000 |
Thioredoxin reductase 1 knockdown enhances selenazolidine cytotoxicity in human lung cancer cells via mitochondrial dysfunction RL Poerschke, PJ Moos Biochemical pharmacology 81 (2), 211-221, 2011 | 82 | 2011 |
Genotoxicity of amorphous silica nanoparticles: Status and prospects M Yazdimamaghani, PJ Moos, MA Dobrovolskaia, H Ghandehari Nanomedicine: Nanotechnology, Biology and Medicine 16, 106-125, 2019 | 70 | 2019 |
Circulating immune cell phenotype dynamics reflect the strength of tumor–immune cell interactions in patients during immunotherapy JI Griffiths, P Wallet, LT Pflieger, D Stenehjem, X Liu, PA Cosgrove, ... Proceedings of the National Academy of Sciences 117 (27), 16072-16082, 2020 | 67 | 2020 |
Differential gene expression in primary human skin keratinocytes and fibroblasts in response to ionizing radiation RL Warters, AT Packard, GF Kramer, DK Gaffney, PJ Moos Radiation research 172 (1), 82-95, 2009 | 66 | 2009 |
Effect of taxol and taxotere on gene expression in macrophages: induction of the prostaglandin H synthase-2 isoenzyme PJ Moos, DT Muskardin, FA Fitzpatrick The Journal of Immunology 162 (1), 467-473, 1999 | 56 | 1999 |
Selenium for the prevention of cutaneous melanoma PB Cassidy, HD Fain, JP Cassidy Jr, SM Tran, PJ Moos, KM Boucher, ... Nutrients 5 (3), 725-749, 2013 | 54 | 2013 |
Oxidation of 2-Cys-peroxiredoxins by arachidonic acid peroxide metabolites of lipoxygenases and cyclooxygenase-2 P Cordray, K Doyle, K Edes, PJ Moos, FA Fitzpatrick Journal of biological chemistry 282 (45), 32623-32629, 2007 | 48 | 2007 |
Diversity of the apoptotic response to chemotherapy in childhood leukemia T Liu, E Raetz, PJ Moos, SL Perkins, CS Bruggers, F Smith, WL Carroll Leukemia 16 (2), 223-232, 2002 | 47 | 2002 |